Novartis AG Sponsored ADR
Price
Key statistics
- Forward rate
- $19.09
- Yield
- 13.55%
- Payout ratio
- 71.60%
- Frequency
- Annual
- 2026-03-11$4.77
Novartis AG Sponsored ADR represents Novartis AG, a global healthcare company focused on developing, manufacturing, and commercializing prescription medicines and related healthcare products. Novartis serves major therapeutic areas including oncology, immunology, cardiovascular, neuroscience, and ophthalmology, with a portfolio built around innovative treatments for serious and chronic diseases. The company operates across research, development, production, and global distribution, supporting hospitals, physicians, and patients in markets worldwide. Novartis also includes medicines and platforms designed to improve access, formulation, and delivery of therapies, making it a significant participant in the pharmaceutical industry and the broader healthcare market. As a sponsored ADR, it provides U.S. investors with access to Novartis shares through an American depositary receipt structure.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 75,883
- Headquarters
- Basel, Switzerland
- Website
- www.novartis.com